Progress of AI-Driven Drug–Target Interaction Prediction and Lead Optimization
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262010037 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Qiqi Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Discovery, Drug Design. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 231 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National High-Level Talents Special Support Program.
Abstract (Originalsprache)
In modern pharmaceutical research and development (R&D), drug discovery remains a challenging process. Artificial intelligence (AI) has been extensively incorporated into various phases of drug discovery and development. AI enable effectively extract molecular structural features, perform in-depth analysis of drug–target interactions, and systematically model the relationships among drugs, targets, and diseases. These approaches improve prediction accuracy, accelerate discovery timelines, reduce costs from trial and error methods, and enhance success probabilities. This review summarizes recent advances in AI applications for drug design, including target identification, synthetic accessibility prediction, lead optimization, and ADMET property evaluation. Furthermore, it introduces various deep learning tools to guide researchers in selecting and implementing the most appropriate AI-driven strategies throughout the drug discovery process. We hope it can establish a conceptual framework intended to advance AI-driven methodologies in pharmaceutical research by comprehensively organizing novel perspectives and critical insights.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
- Technology Innovation Center for Food Safety Surveillance and Detection (Hainan), Sanya Institute of China Agricultural University, Sanya 572025, China.
- Shandong Provincial Animal and Poultry Green Health Products Creation Engineering Laboratory, Institute of Poultry Science, Shandong Academy of Agricultural Science, 202 Gongyebeilu Jinan, Jinan 250023, China.
- Department of Pharmacology, Biodiscovery Institute, Monash University, Clayton, VIC 3800, Australia.
ORCID-Profile: Yunpeng Yi, Tony Velkov, Chongshan Dai, Haiyang Jiang
Förderung
- National Key Research and Development Program of China
- National High-Level Talents Special Support Program
Zitieren
APA
Wang, Q., Sun, B., Yi, Y., Velkov, T., Shen, J., Dai, C., & Jiang, H. (2025). Progress of AI-Driven Drug–Target Interaction Prediction and Lead Optimization. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010037
Vancouver
Wang Q, Sun B, Yi Y, Velkov T, Shen J, Dai C, et al. Progress of AI-Driven Drug–Target Interaction Prediction and Lead Optimization. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010037
BibTeX
@article{Wang2025,
author = {Wang, Qiqi and Sun, Boyan and Yi, Yunpeng and Velkov, Tony and Shen, Jianzhong and Dai, Chongshan and Jiang, Haiyang},
title = {Progress of AI-Driven Drug–Target Interaction Prediction and Lead Optimization},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262010037}
}
EUVIMED